Neuroimaging specialists are healthcare professionals skilled in using advanced imaging techniques to diagnose and monitor neurological conditions. They work primarily with technologies such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and functional MRI (fMRI) to obtain detailed images of the brain, spinal cord, and nervous system. These specialists often come from backgrounds in radiology, neurology, or neuroscience and undergo additional training to interpret complex imaging results accurately. Their expertise is essential in identifying structural abnormalities like tumors, hemorrhages, and strokes, as well as functional disorders including epilepsy and neurodegenerative diseases. By providing critical information about brain anatomy and function, neuroimaging specialists help guide clinical decisions and treatment plans.
In clinical settings, neuroimaging specialists collaborate closely with neurologists, neurosurgeons, and other medical professionals to assess patients and track disease progression. They play a vital role in pre-surgical planning, helping to map out critical areas of the brain to minimize risks during procedures. Recent advances in imaging technology have enhanced the ability to visualize brain activity, blood flow, and metabolic changes, enabling earlier diagnosis and more personalized treatment approaches. Neuroimaging specialists also contribute to research by using imaging tools to better understand brain disorders and develop new therapies. Their work is crucial for improving neurological care and deepening our knowledge of the complex human brain.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States